Modified-Release Minoxidil Formulation for Controlled Serum Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current formulations of minoxidil for treating hair loss do not provide a controlled release mechanism, leading to variable absorption and potential adverse effects due to peak serum concentrations.
Innovation Solution
A modified release formulation of minoxidil that releases 50% to 98% of the daily dose within 12 hours, with a Tmax of 30 to 360 minutes and Cmax of 0.25 ng/ml to 20 ng/ml, ensuring a steady and controlled absorption profile.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If immediate release formulation of minoxidil is used, then rapid absorption is achieved, but peak serum concentrations cause adverse effects
Solution Approach 1:
The patent applies dynamics by transitioning from static immediate release to dynamic modified release, where the formulation adapts its release rate over time. The minoxidil is released in a controlled manner with initial burst followed by sustained release, matching the physiological needs while avoiding toxic peaks.
Solution Approach 2:
The patent changes the release rate parameter from constant (immediate release) to time-dependent (modified release). By controlling the release kinetics parameters, the formulation achieves rapid initial absorption followed by gradual release, maintaining serum levels within therapeutic window and avoiding adverse effects.
2Loss of time
If immediate release formulation is used, then quick onset of action is achieved, but variable absorption reduces treatment reliability
Solution Approach 1:
The patent ensures continuity of useful action by designing a modified release formulation that provides continuous minoxidil release over an extended period. This continuous release profile maintains steady serum concentrations, eliminating the variability associated with immediate release while preserving rapid onset through initial burst release.
3Stability of the object's composition
If modified release formulation is designed, then controlled absorption is achieved, but formulation complexity increases
Solution Approach 1:
The patent employs composite materials by combining minoxidil with specific excipients and delivery systems that enable modified release. This composite approach achieves stable serum concentrations through controlled release mechanisms while managing formulation complexity through established pharmaceutical technologies.
Data Source
AI summary
The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.